SORRENTO THERAPEUTICS INC's ticker is SRNE and the CUSIP is 83587F202. A total of 225 filers reported holding SORRENTO THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.77 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $556,342 | +595.4% | 627,926 | +1135.0% | 0.00% | – |
| Q3 2022 | $80,000 | -88.0% | 50,844 | -82.3% | 0.00% | -100.0% |
| Q1 2022 | $668,000 | +507.3% | 286,694 | +1885.1% | 0.00% | – |
| Q3 2021 | $110,000 | -74.4% | 14,442 | -67.4% | 0.00% | -100.0% |
| Q2 2021 | $429,000 | -84.3% | 44,314 | -86.6% | 0.00% | -87.5% |
| Q1 2021 | $2,741,000 | +966.5% | 331,392 | +780.4% | 0.02% | +700.0% |
| Q4 2020 | $257,000 | -63.5% | 37,643 | -40.4% | 0.00% | -77.8% |
| Q3 2020 | $704,000 | +1000.0% | 63,175 | +517.8% | 0.01% | +800.0% |
| Q2 2020 | $64,000 | -16.9% | 10,225 | -75.7% | 0.00% | -50.0% |
| Q1 2020 | $77,000 | -85.9% | 42,000 | -74.0% | 0.00% | -33.3% |
| Q4 2019 | $545,000 | +1918.5% | 161,262 | +1085.6% | 0.00% | +200.0% |
| Q2 2017 | $27,000 | -65.8% | 13,602 | -15.6% | 0.00% | -66.7% |
| Q4 2016 | $79,000 | – | 16,116 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Wildcat Capital Management, LLC | 2,623,533 | $22,851,000 | 6.45% |
| Avoro Capital Advisors LLC | 1,146,579 | $9,987,000 | 3.44% |
| Cormorant Asset Management, LP | 2,095,334 | $18,250,000 | 2.18% |
| Healthcare Value Capital, LLC | 50,000 | $436,000 | 0.72% |
| CAPITAL MANAGEMENT ASSOCIATES /NY/ | 20,000 | $174,000 | 0.25% |
| SABBY MANAGEMENT, LLC | 300,000 | $2,613,000 | 0.14% |
| STRATEGIC INVESTMENT MANAGEMENT, LLC | 20,398 | $177,000 | 0.10% |
| Granite Investment Partners, LLC | 89,622 | $781,000 | 0.07% |
| LANDSCAPE CAPITAL MANAGEMENT, L.L.C. | 54,634 | $476,000 | 0.06% |
| Trexquant Investment LP | 67,929 | $592,000 | 0.05% |